Search results
Results from the WOW.Com Content Network
The first-ever needle-free alternative to the EpiPen and similar epinephrine autoinjectors has been approved by the Food and Drug Administration to treat anaphylaxis.. Neffy, a nasal spray that ...
The spray, which will be sold under the brand name neffy, is seen as an alternative to EpiPen and other autoinjectors that are filled with epinephrine, a life-saving drug used by people at risk of ...
The FDA will review the nasal spray again and is expected to decide on its approval by Oct. 2. William Blair analyst Tim Lugo said the EU recommendation bodes well for a FDA approval.
The EpiPen had 89% of the market for epinephrine autoinjectors in 2015; [57] in the first half of the year it had about 85% share and Auvi-Q had about 10% share. [29] In March 2016, Teva's ANDA for a generic EpiPen, which had already faced several delays, was rejected by the FDA. [77]
use of vaccines and other immunobiologic agents in clinical practice or preventive medicine; clinical or laboratory vaccine research; assessment of vaccine efficacy and safety; consumer perspectives and/or social and community aspects of immunization programs; at least one member must be an expert in this category.
Epinephrine vial 1 mg (Adrenalin). Epinephrine is used to treat a number of conditions, including cardiac arrest, anaphylaxis, and superficial bleeding. [25] It has been used historically for bronchospasm and low blood sugar, but newer treatments for these that are selective for β 2 adrenoceptors, such as salbutamol, are preferred.
The Centers for Medicare & Medicaid Services confirmed to lawmakers that the drug company that makes EpiPen, has been overcharging the government. CONFIRMED: The maker of EpiPen overcharged the ...
Secretary of Health and Human Services, Cell-based vaccine, Cervarix, ChAdOx1, Chandos Leigh Hunt Wallace, Charles Alfred Tyrrell, Chicken anemia virus, Cholera vaccine, CimaVax-EGF, CircoFLEX, Clinical and Vaccine Immunology, Conjugate vaccine, Convidecia, Corbevax, CoronaVac, Covaxin, COVID-19 drug development, COVID-19 misinformation, COVID ...